Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-04937319 is an activator of glucokinase (EC50 =154.4 μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
2 mg | In stock | $ 53.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 322.00 | |
50 mg | In stock | $ 587.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | PF-04937319 is an activator of glucokinase (EC50 =154.4 μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus. |
Targets&IC50 | GK:154.4 μM(EC50) |
Molecular Weight | 432.43 |
Formula | C22H20N6O4 |
CAS No. | 1245603-92-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (219.69 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-04937319 1245603-92-2 Metabolism Others Glucokinase Inhibitor Hexokinase IV PF 04937319 PF04937319 Hexokinase D inhibit inhibitor